SEC 13F Intelligence

Patient Capital Management, LLC / DXC

Patient Capital Management, LLC’s Dxc Technology Co Position

Does Patient Capital Management, LLC own Dxc Technology Co (DXC)? Not currently — the last reported position was 1.20M shares worth $25M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$25M
Q3 2023
Shares
1.20M
% of Portfolio
+1.46%
Quarters Held
8
position exited

Position History DXC

Reported value by quarter
Q4 ’21: $10MQ4 ’21Q1 ’22: $10MQ1 ’22Q2 ’22: $8MQ2 ’22Q3 ’22: $5MQ3 ’22Q4 ’22: $4MQ4 ’22Q1 ’23: $2MQ1 ’23Q2 ’23: $3MQ2 ’23Q3 ’23: $25MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20231.20M$25M+1.46%
Q2 2023102.8K$3M+0.15%
Q1 202360.0K$2M+0.68%
Q4 2022160.6K$4M+2.07%
Q3 2022190.0K$5M+2.32%
Q2 2022271.6K$8M+3.65%
Q1 2022301.6K$10M+3.33%
Q4 2021323.7K$10M+3.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Patient Capital Management, LLC’s full portfolio or all institutional holders of DXC.